Gene Therapy Co. Selects ValGenesis' SaaS Platform

ValGenesis, Inc., a provider of in Enterprise Validation Lifecycle Management Systems (VLMS), was selected by a gene therapy company to digitize its corporate validation process. The company discovers and develops gene therapies that are helping patients overcome limitations in genetic disease.

ValGenesis VLMS offers remote validation capability and is designed to enable efficient change and risk management to help achieve better control over these processes. ValGenesis VLMS expedites protocol execution and evidence capture in real-time. It’s also designed to reduce the duration of change control driven validation activities from weeks to hours. The VLMS also enables data integrity governance and provides fast access to detailed metrics, reducing cycle time and costs.

"In these times of a global pandemic, the ValGenesis VLMS is truly a unique solution, empowering organizations to simplify their validation concerns through remote monitoring and management capabilities. With the ValGenesis VLMS, this company will be able to experience all the benefits of digitization for maximized system efficiency, process consistency, standardization, and reduced validation cycle time. We are excited to serve their needs today and look forward to supporting their broadening use of our system across their enterprise," says Narayan Raj, Sr. Vice President of Global Sales & Operations at ValGenesis, Inc.